Accuracy of serological testing for the diagnosis of prevalent neurocysticercosis in outpatients with epilepsy, Eastern Cape Province, South Africa

PLoS Neglected Tropical Diseases

Volumn 3, Issue 12, 2009, Pages

  Foyaca Sibat, Humberto ^a   Cowan, Linda D ^b   Carabin, Hélène ^b   Targonska, Irene ^a   Anwary, Mushtaq A ^a   Serrano Ocaña, Gilberto ^c   Krecek, Rosina C ^d,e   Willingham III, A Lee ^f  

^a Walter Sisulo University   (South Africa)

^b UNIVERSITY OF OKLAHOMA HEALTH SCIENCES CENTER   (United States)

^c Dora Nginza Hospital   (South Africa)

^d Ross University   (Saint Kitts and Nevis)

^e UNIVERSITY OF JOHANNESBURG   (South Africa)

^f UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; CYSTICERCOSIS; DIAGNOSTIC ACCURACY; EPILEPSY; FALSE POSITIVE RESULT; FEMALE; HUMAN; IMMUNOASSAY; MAJOR CLINICAL STUDY; MALE; NEUROCYSTICERCOSIS; NEUROIMAGING; PRESCHOOL CHILD; PREVALENCE; SCHOOL CHILD; SENSITIVITY AND SPECIFICITY; SEROLOGY; SOUTH AFRICA; TAENIA SOLIUM; ANIMAL; BLOOD; CROSS-SECTIONAL STUDY; EVALUATION; IMMUNOLOGY; METHODOLOGY; MIDDLE AGED; OUTPATIENT; PARASITOLOGY;

HELMINTH ANTIBODY;

ADOLESCENT; ADULT; AGED; ANIMALS; ANTIBODIES, HELMINTH; CHILD; CHILD, PRESCHOOL; CROSS-SECTIONAL STUDIES; EPILEPSY; FEMALE; HUMANS; MALE; MIDDLE AGED; NEUROCYSTICERCOSIS; OUTPATIENTS; PREVALENCE; SEROLOGIC TESTS; SOUTH AFRICA; TAENIA SOLIUM; YOUNG ADULT;

EID: 74549172102     PISSN: None     EISSN: None     Source Type: Journal    
DOI: 10.1371/journal.pntd.0000562     Document Type: Article

References (35)

1. Prabhakar S, Singh G (2002) Neurocysticercosis: an overview of clinical presentations. In: Singh G, Prabhakar S, eds. Taenia solium cysticercosis. From basic to clinical science. New York: CAB International. pp 169-176.
2. Pawlowski ZS (2002) Taenia solium: Basic biology and transmission. In: Singh G, Prabhakar S, eds (2002) Taenia solium cysticercosis. From basic to clinical science. New York: CAB International. pp 1-13.
3. Bern C, Garcia HH, Evans C, Gonzalez AE, Verastegui M, et al. (1999) Magnitude of the disease burden from neurocysticercosis in a developing country. Clin Infect Dis 29: 1203-1209.
4. Pal DK, Carpio A, Sander JWAS (2000) Neurocysticercosis and epilepsy in developing countries. J Neurol Neurosurg Psychiatry 68: 137-143.
5. Nash TE, Del Brutto OH, Butman JA, Corona T, Delgado-Escueta A, et al. (2004) Calcific neurocysticercosis and epileptogenesis. Neurology 62: 1934-1938.
6. Cukiert A, Puglia P, Scapolan HB, Vilela MM, Marino Junior R (1994) Congruence of the topography of intracranial calcifications and epileptic foci. Arq Neuropsiquiatr 52: 289-294.
7. Bergen DC (1998) Preventable neurological diseases worldwide. Neuroepidemiol 17: 67-73.
8. Roman G, Sotelo J, Del Brutto O, Flisser A, Dumas M, et al. (2000) A proposal to declare neurocysticercosis an international reportable disease. Bull WHO 78: 399-406.
9. Preux P-M, Druet-Cabanac M (2005) Epidemiology and aetiology of epilepsy in sub-Saharan Africa. Lancet Neurol 4: 21-31.
10. Garcia HH, Gilman R, Martinez M, Tsang VC, Pilcher JB, et al. (1993) Cysticercosis as a major cause of epilepsy in Peru. The Cysticercosis Working Group in Peru (CWG). Lancet 341: 197-200.
11. Nsengiyumva G, Druet-Cabanac M, Ramankandrasana B, Bouteille B, Nsizabira L, et al. (2003) Cysticercosis as a major risk factor for epilepsy in Burundi, East Africa. Epilepsia 44: 950-955.
12. Garcia HH, Gilman Rh, Catacora M, Verastegui M, Gonzalez AE, et al. (1997) Serologic evolution of neurocysticercosis patients after antiparasitic therapy. J Infect Dis 175: 486-489.
13. Proano-Narvaez JV, Meza-Lucas A, Mata-Ruiz O, Garcia-Jeronimo RC, Correa D (2002) Laboratory diagnosis of human neurocysticercosis: Doubleblind comparison of enzyme-linked immunosorbent assay and electroimmunotransfer blot assay. J Clin Microbiol 40: 2115-8.
14. Garcia HH, Del Brutto OH (2005) Neurocysticercosis: updated concepts about an old disease. Lancet Neurol 4: 653-661.
15. Rajshekhar V, Raghava MV, Prabhakaran V, Oommen A, Muliyil J (2006) Active epilepsy as an index of burden of neurocysticercosis in Vellore district, India. Neurology 67: 2135-2139.
16. Del Brutto OH, Rajshekhar V, White AC Jr, Tsang VC, Nash TE, et al. (2001) Proposed diagnostic criteria for neurocysticercosis. Neurology 57: 177-183.
17. Statistics South Africa (2004) Census 2001: Primary Tables Eastern Cape 1996 and 2001 Compared. Pretoria: Statistics South Africa. Report Number 03-02-05.
18. Commission on Classification and Terminology. International League Against Epilepsy (1981) Proposal for revised clinical and electroencephalographic classification of epileptic seizures. Epilepsia 22: 489-501.
19. Commission on Classification and Terminology. International League Against Epilepsy (1989) Proposal for classification of epilepsies and epileptic syndromes. Epilepsia 30: 389-399.
20. Dorny P, Brandt J, Zoli A, Geerts S (2003) Immunodiagnostic tools for human and porcine cysticercosis. Acta Trop 87: 79-86.
21. Dorny P, Vercammen F, Brandt J, Vansteenkiste W, Berkvens D, et al. (2000) Sero-epidemiological study of Taenia saginata cysticercosis in Belgian cattle. Vet Parasitol 88: 43-49.
22. Sokal RR, Rohlf JF (1981) Biometry: The Principles and Practice of Statistics in Biological Research. New York: WH Freeman Co..
23. Clopper C, Pearson S (1934) The use of confidence or fiducial limits illustrated in the case of the binomial. Biometrika 26: 404-413.
24. Kabore J, Lengani A, Drabo YJ, Melaku Z, Preux PM, et al. (1995) Clinical aspects of seizure disorders at Ouagadougou Burkina Faso: retrospective study of 532 cases. Afr J Neurol Sci 14: 24-26.
25. Druet-Cabanac M, Ramanankandrasana B, Bisser S, Dongmo L, Avodé G, et al. (2002) Taenia solium cysticercosis in Africa. In: Singh G, Prabhakar S, eds. Taenia solium cysticercosis. From basic to clinical science. New York: CAB International. pp 129-137.
26. Mafojane NA, Appleton CC, Krecek RC, Michael LM, Willingham AL (2003) The current status of neurocysticercosis in Eastern and Southern Africa. Acta Trop 87: 25-34.
27. Del Brutto OH, Noboa CA (1991) Late-onset epilepsy in Ecuador: aetiology and clinical features in 225 patients. J Trop Geograph Neurol 1: 31-34.
28. Salinas P, Sandoval L, Rugiero E, Conteras MC (1996) [Diagnosis of human neurocysticercosis by ELISA-IgG using a purified antigen]. Bol Chil Parasitol 51: 85-90.
29. Wilson M, Bryan RT, Fried JA, Ware DA, Schantz PM, et al. (1991) Clinical evaluation of the cysticercosis enzyme-linked immunoelectrotransfer blot in patients with neurocysticercosis. 164: 1007-9.
30. Singh G, Kaushal V, Ram S, Kaushal RK, Dhanuka AK, et al. (1999) Cysticercus immunoblot assay in patients with single, small enhancing lesions and multilesional neurocysticercosis. J Assoc Physicians India 47: 476-479.
31. Dixon HBF, Lipscomb FM (1961) Cysticercosis: an analysis and follow-up of 450 cases. London: Privy Council, Medical Research Council. pp 1-58.
32. Garcia HH, Martinez M, Gilman R, Herrera G, Tsang VCW, et al. (1991) Diagnosis of cysticercosis in endemic regions. Lancet 338: 549-551.
33. Carpio A (2002) Neurocysticercosis: an update. Lancet Infect Dis 2: 751-762.
34. Palacios E, Lujamio PS, Jasso RR (1997) Computed tomography and magnetic resonance imaging of neurocysticercosis. Seminars Roentgen 32: 325-334.
35. Garcia HH, Del Brutto OH (2003) Imaging findings in neurocysticercosis. Acta Trop 87: 71-78.